Novo Nordisk(NVO) - 2025 Q3 - Earnings Call Transcript
Novo Nordisk (NYSE:NVO) Q3 2025 Conference November 06, 2025 06:40 AM ET Company ParticipantsKarsten Munk Knudsen - CFOKerry Holford - Head of Global Pharmaceutical Equity ResearchJames Quigley - Executive DirectorRichard Vosser - Managing DirectorHarry Sephton - Director of Pharma Equity ResearchSimon Baker - Partner and Head of Global Biopharma ResearchYihan Li - VP of Biophama Equity ResearchJacob Martin Wiborg Rode - Head of Investor RelationsSachin Jain - VPEvan Seigerman - Managing DirectorMartin Hols ...